216 related articles for article (PubMed ID: 29271533)
1. Eltrombopag with i.v. immunoglobulin for safe splenectomy in refractory immune thrombocytopenia.
Kanno M; Onoda T; Meguro T; Sato H; Mitsui T
Pediatr Int; 2018 Feb; 60(2):191-192. PubMed ID: 29271533
[No Abstract] [Full Text] [Related]
2. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
[TBL] [Abstract][Full Text] [Related]
3. [Thrombopoietin-receptor agonists: a revolution in the therapeutic strategies of immune thrombocytopenic purpura?].
Godeau B;
Rev Med Interne; 2009 Mar; 30(3):203-5. PubMed ID: 19019500
[No Abstract] [Full Text] [Related]
4. [Trombopag for chronic immune thrombocytopenia in a patient previously treated with romiplostim].
Rodríguez Vargas B; Serna Pérez J; Bermejo Vicedo T
Farm Hosp; 2013; 37(3):265-6. PubMed ID: 23789804
[No Abstract] [Full Text] [Related]
5. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
[TBL] [Abstract][Full Text] [Related]
6. Management of Primary Immune Thrombocytopenia With Eltrombopag in a Patient With Recent Acute Coronary Syndrome.
Bermejo N; Sigüenza R; Ibáñez F
Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):56-57. PubMed ID: 27650208
[No Abstract] [Full Text] [Related]
7. Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
Depré F; Aboud N; Mayer B; Salama A
PLoS One; 2018; 13(6):e0198184. PubMed ID: 29856800
[TBL] [Abstract][Full Text] [Related]
8. [New treatment options for primary immune thrombocytopenia].
Gudbrandsdottir S; Frederiksen H; Birgens HS; Nielsen CH; Nielsen OJ; Stentoft J; Hasselbalch HC
Ugeskr Laeger; 2011 Jan; 173(4):271-4. PubMed ID: 21262171
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab.
Ruiz-Arguelles GJ; Ruiz-Delgado GJ; Velázquez-Sánchez-de-Cima S; Zamora-Ortiz G
Hematology; 2013 May; 18(3):175-7. PubMed ID: 23321502
[TBL] [Abstract][Full Text] [Related]
10. Refractory idiopathic thrombocytopenic purpura treated with immunoadsorption using tryptophan column.
Kurtoğlu E; Karakuş V; Deveci B
Transfus Apher Sci; 2013 Jun; 48(3):311-2. PubMed ID: 23628355
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic immune thrombocytopenic purpura. Looking for something better. Review].
Vizcaíno G; Diez-Ewald M; Vizcaíno-Carruyo J
Invest Clin; 2009 Mar; 50(1):95-108. PubMed ID: 19418731
[TBL] [Abstract][Full Text] [Related]
12. [Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia].
Sanz MÁ; Vicente García V; Fernández A; López MF; Grande C; Jarque I; Martínez R; Mingot ME; Monteagudo E; Ribera JM; Valcárcel D; ;
Med Clin (Barc); 2012 Mar; 138(6):261.e1-261.e17. PubMed ID: 22257609
[TBL] [Abstract][Full Text] [Related]
13. [Novelties in the treatment of pediatric immune thrombocytopenia - 2017].
Kovács G; Kiss C
Orv Hetil; 2017 Dec; 158(48):1891-1896. PubMed ID: 29172661
[TBL] [Abstract][Full Text] [Related]
14. Emerging strategies to treat chronic immune thrombocytopenic purpura.
Newland A
Eur J Haematol Suppl; 2008 Feb; (69):27-33. PubMed ID: 18211570
[TBL] [Abstract][Full Text] [Related]
15. Successful use of eltrombopag in a child with refractory immune thrombocytopenia: case study and literature review.
Wang XL; Li AM
Blood Coagul Fibrinolysis; 2016 Oct; 27(7):825-827. PubMed ID: 26650460
[TBL] [Abstract][Full Text] [Related]
16. Eltrombopag in thrombocytopenia.
Zimmer J; Hentges F; Andrès E
N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18326076
[No Abstract] [Full Text] [Related]
17. Spotlight on eltrombopag in treatment-refractory chronic primary immune thrombocytopenia.
Garnock-Jones KP
BioDrugs; 2011 Dec; 25(6):401-4. PubMed ID: 22050343
[TBL] [Abstract][Full Text] [Related]
18. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
Mori M; Kato M; Koh K; Hanada R
Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
[TBL] [Abstract][Full Text] [Related]
19. What is publication? The case of eltrombopag.
Benham L; Guo L; Turner R
Lancet; 2011 Jan; 377(9763):360-1. PubMed ID: 21277427
[No Abstract] [Full Text] [Related]
20. Eltrombopag--an oral thrombopoietin agonist.
Sharma V; Randhawa H; Sharma A; Aggarwal S
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):743-6. PubMed ID: 22913204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
